RAPS Convergence 2025 Banner

Location: Pittsburgh, Pennsylvania

Date:

Event description:

The largest annual gathering of regulatory professionals brings together leaders to advance high-impact regulatory science and practice. Novotech’s Drug Development Consulting team will be on site to discuss regulatory strategy, risk-based approaches, and inclusive trial design, helping sponsors align programs with evolving expectations and accelerate decision-making.

Attendees:

  • Scott Schliebner — Global Head, Drug Development Consulting.
  • Ingrid Leth — Senior Scientific Consultant.

Speaker & Presentation:

Scott Schliebner will present on “Enhancing Understanding of Biologic Variability Through Representation in Clinical Trials”

Date/Time: October 8, 9:15–10:30 a.m.

Please join the session, and if you’d like to connect with our team at the conference, please fill out the form on this page to request a meeting.

This event has concluded

Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.

Have a question or want to continue the conversation?

Talk to a Clinical Development Expert

Meet Our Team

Novotech

Scott Schliebner

Novotech
Vice President - Drug Development Consulting
Drug Development Consulting

Ingrid Leth

Drug Development Consulting
Senior Scientific Consultant

Plus experts from our China, Drug Development, and global Commercial teams.